The direct effect of lobeglitazone, a new thiazolidinedione, on pancreatic beta cells: A comparison with other thiazolidinediones

This publication has 51 references indexed in Scilit:

• PPAR-γ Activation Increases Insulin Secretion through the Up-regulation of the Free Fatty Acid Receptor GPR40 in Pancreatic β-Cells
  PLOS ONE, 2013
• Effects of Rosiglitazone, Glyburide, and Metformin on β-Cell Function and Insulin Sensitivity in ADOPT
  Diabetes, 2011
• The role of peroxisome proliferator‐activated receptor γ in pancreatic β cell function and survival: therapeutic implications for the treatment of type 2 diabetes mellitus
  Diabetes, Obesity and Metabolism, 2010
• Molecular mechanism by which pioglitazone preserves pancreatic β-cells in obese diabetic mice: evidence for acute and chronic actions as a PPARγ agonist
  American Journal of Physiology-Endocrinology and Metabolism, 2010
• From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus
  Diabetes, 2009
• Peroxisome Proliferator-Activated Receptor γ Activation Restores Islet Function in Diabetic Mice through Reduction of Endoplasmic Reticulum Stress and Maintenance of Euchromatin Structure
  Molecular and Cellular Biology, 2009
• Selective modulation of promoter recruitment and transcriptional activity of PPARγ
  Biochemical and Biophysical Research Communications, 2007
• Differential regulation and properties of MAPKs
  Oncogene, 2007
• Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial
  The Lancet, 2006
• Glucagon Promotes cAMP-response Element-binding Protein Phosphorylation via Activation of ERK1/2 in MIN6 Cell Line and Isolated Islets of Langerhans
  Journal of Biological Chemistry, 2004